MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

Search

Elanco Animal Health Inc

Closed

Sector Healthcare

11.03 -0.99

Overview

Share price change

24h

Current

Min

10.94

Max

11.05

Key metrics

By Trading Economics

Income

414M

364M

Sales

-154M

1B

P/E

Sector Avg

27.415

73.394

EPS

0.13

Profit margin

35.34

Employees

9,300

EBITDA

592M

787M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+48.82 upside

Dividends

By Dow Jones

Next Earnings

25 Feb 2025

Market Stats

By TradingEconomics

Market Cap

5.6B

Previous open

12.02

Previous close

11.03

News Sentiment

By Acuity

44%

56%

144 / 393 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Elanco Animal Health Inc Chart

Past performance is not a reliable indicator of future results.

Related News

27 Jun 2024, 14:34 UTC

Major Market Movers

Elanco Shares Retreat Over Zenrelia Warning Label Concerns

9 Jul 2024, 12:30 UTC

Acquisitions, Mergers, Takeovers

Merck Animal Health Completes Acquisition Of Elanco's Aqua Business >MRK

9 Jul 2024, 12:29 UTC

Acquisitions, Mergers, Takeovers

Elanco Animal Health Sees Ending 2024 With Net Debt to Adjusted Ebitda in Mid-4x Range >ELAN

9 Jul 2024, 12:28 UTC

Acquisitions, Mergers, Takeovers

Elanco Animal Health: $1.05B-$1.1B Net Proceeds Available for Debt Paydown in 3Q >ELAN

9 Jul 2024, 12:28 UTC

Acquisitions, Mergers, Takeovers

Elanco Completes Sale of Aqua Business to Merck >ELAN MRK

2 May 2024, 17:43 UTC

Earnings

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 May 2024, 13:06 UTC

Earnings

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

Peer Comparison

Price change

Elanco Animal Health Inc Forecast

Price Target

By TipRanks

48.82% upside

12 Months Forecast

Average 16.4 USD  48.82%

High 20 USD

Low 14 USD

Based on 5 Wall Street analysts offering 12 month price targets forElanco Animal Health Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

5 ratings

3

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

10.765 / 11.31Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

144 / 393 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.